References
- Bruyndonckx RB, Meulemans AI, Sabbe MB, Kumar AA, Delooz HH. Fatal intentional poisoning cases admitted to the University Hospitals of Leuven, Belgium from 1993 to 1996. Eur J Emerg Med 2002; 9:238–243.
- Shin SD, Suh GJ, Rhee JE, Sung J, Kim J. Epidemiologic characteristics of death by poisoning in 1991–2001 in Korea. J Korean Med Sci 2004; 19:186–194.
- Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, Remião F, Bastos ML, Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol 2008; 38:13–71.
- Smith LL. Mechanism of paraquat toxicity in lung relevance to treatment. Hum Toxicol 1987; 6:31–36.
- Lei XG, Cheng WH, McClung JP. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr 2007; 27:41–61.
- Birringer M, Pilawa S, Flohe L. Trends in selenium biochemistry. Nat Prod Rep 2002; 19:693–718.
- Burk RF, Hill KE, Motley AK. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 2003; 133:1517S–1520S.
- Cheng W, Fu YX, Porres JM, Ross DA, Lei XG. Selenium-dependent cellular glutathione peroxidase protects mice against a pro-oxidant-induced oxidation of NADPH, NADH, lipids, and protein. FASEB J 1999; 13:1467–1475.
- Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach JM, . Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized double-blind, phase II study. Crit Care 2007; 11:R73.
- Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, . Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007; 35:118–126.
- Jo YH, Kim K, Rhee JE, Suh GJ, Kwon WY, Na SH, Alam HB. Therapeutic hypothermia attenuates acute lung injury in paraquat intoxication in rats. Resuscitation 2011; 82:487–491.
- Ceballos-Picot I, Trivier JM, Nicole A, Sinet PM, Thevenin M. Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem 1992; 38:66–70.
- Lee J, Kwon W, Jo Y, Suh G, Youn Y. Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats. Hum Exp Toxicol 2008; 27:49–54.
- Kwon WY, Suh GJ, Kim KS, Kwak YH. Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-B pathway. Crit Care Med 2011; 39:328–334.
- Kwon WY, Suh GJ, Kim KS, Jo YH, Lee JH, Kim K, Jung SK. Glutamine attenuates acute lung injury by inhibition of high mobility group box protein-1 expression during sepsis. Br J Nutr 2010; 103: 890–898.
- Festing MF, Altman DG. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 2002; 43:244–258.
- Manzanares W, Biestro A, Galusso F, Torre MH, Mañáy N, Facchin G, Hardy G. High-dose selenium for critically ill patients with systemic inflammation: pharmacokinetics and pharmacodynamics of selenious acid: a pilot study. Nutrition 2010; 26:634–640.
- Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009; 390:191–214.
- Kanzok SM, Fechner A, Bauer H, Ulschmid JK, Müller HM, Botella-Munoz J, . Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster. Science 2001; 291:643–646.
- Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, . Scottish intensive care glutamine or selenium evaluative trial trials group. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2011; 342:d1542.
- Heyland DK, Dhaliwal R, Suchner U, Berger M. Antioxidant nutrients: a systematic review of vitamins and trace elements in the critically ill patient. Intensive Care Med. 2005; 31:327–337.
- Heyland DK. Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing?Crit Care 2007; 11:153
- van der Hoorn JW, de Haan W, Berbée JF, Havekes LM, Jukema JW, Rensen PC, Princen HM. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice. Arterioscler Thromb Vasc Biol 2008; 28:2016–2022.
- Aldosary BM, Sutter ME, Schwartz M, Morgan BW. Case series of selenium toxicity from a nutritional supplement. Clin Toxicol 2012; 50:57–64.